|
G
|
Ache
|
acetylcholinesterase
|
multiple interactions increases activity
|
EXP
|
thymoquinone inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein]; trandolapril inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein]
|
CTD |
PMID:25445565 PMID:27206696 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased phosphorylation of AKT1 protein methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of AKT1 protein]]; N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of AKT1 protein]; Topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of AKT1 protein]; Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:29753867 PMID:36509115 PMID:38513929 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions increases expression
|
EXP
|
naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAD mRNA]
|
CTD |
PMID:21945202 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
affects localization multiple interactions increases expression
|
EXP
|
3-nitropropionic acid affects the localization of BAX protein [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein; Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA]; methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of BAX protein]]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of BAX protein]; ursodoxicoltaurine inhibits the reaction [3-nitropropionic acid affects the localization of BAX protein] 3-nitropropionic acid results in increased expression of BAX mRNA; 3-nitropropionic acid results in increased expression of BAX protein
|
CTD |
PMID:11080188 PMID:15571979 PMID:21827809 PMID:21945202 PMID:38513929 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
EXP ISO
|
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein; BCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 protein]]; naringin inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 mRNA]; Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 protein] 3-nitropropionic acid results in decreased expression of BCL2 mRNA; 3-nitropropionic acid results in decreased expression of BCL2 protein 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2 protein]]
|
CTD |
PMID:15571979 PMID:19428112 PMID:21945202 PMID:37308051 PMID:38513929 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression multiple interactions
|
EXP ISO
|
3-nitropropionic acid results in decreased expression of BCL2L1 mRNA Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2L1 mRNA] 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in decreased expression of BCL2L1 protein]]
|
CTD |
PMID:21827809 PMID:37308051 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G
|
Bdnf
|
brain-derived neurotrophic factor
|
decreases response to substance multiple interactions decreases expression
|
EXP
|
BDNF protein results in decreased susceptibility to 3-nitropropionic acid BCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; Dinitrochlorobenzene inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; KT 5823 inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased expression of BDNF protein]; Topiramate inhibits the reaction [3-nitropropionic acid results in decreased expression of BDNF protein]
|
CTD |
PMID:19428112 PMID:29753867 PMID:36509115 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G
|
Casp2
|
caspase 2
|
increases activity
|
EXP
|
3-nitropropionic acid results in increased activity of CASP2 protein
|
CTD |
PMID:15571979 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G
|
Casp3
|
caspase 3
|
increases activity multiple interactions increases cleavage increases expression
|
EXP ISO
|
3-nitropropionic acid results in increased activity of CASP3 protein methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of CASP3 protein]]; naringin inhibits the reaction [3-nitropropionic acid results in increased cleavage of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Topiramate inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of CASP3 protein] 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of CASP3 protein]]
|
CTD |
PMID:15571979 PMID:21945202 PMID:29753867 PMID:37308051 PMID:38513929 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Casp8
|
caspase 8
|
increases activity
|
EXP
|
3-nitropropionic acid results in increased activity of CASP8 protein
|
CTD |
PMID:15571979 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G
|
Casp9
|
caspase 9
|
increases activity
|
EXP
|
3-nitropropionic acid results in increased activity of CASP9 protein
|
CTD |
PMID:15571979 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
multiple interactions decreases expression decreases activity
|
EXP
|
3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; 3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; 3-nitropropionic acid affects the reaction [Ethanol affects the expression of CAT protein]; Cyclosporine inhibits the reaction [3-nitropropionic acid results in decreased expression of CAT protein]; naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; Nitric Oxide promotes the reaction [Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Nitric Oxide promotes the reaction [Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; trandolapril inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]
|
CTD |
PMID:20305041 PMID:20448265 PMID:21945202 PMID:25445565 PMID:27206696 PMID:31550440 PMID:37116597 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Ccnd1
|
cyclin D1
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of CCND1 protein
|
CTD |
PMID:21827787 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of CDK4 protein
|
CTD |
PMID:21827787 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
|
|
G
|
Cnr1
|
cannabinoid receptor 1
|
affects expression
|
EXP
|
3-nitropropionic acid affects the expression of CNR1 mRNA
|
CTD |
PMID:15640759 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
|
|
G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
decreases expression
|
ISO
|
3-nitropropionic acid results in decreased expression of COX4I1 mRNA
|
CTD |
PMID:19306371 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:48,721,199...48,727,921
|
|
G
|
Cox4i2
|
cytochrome c oxidase subunit 4i2
|
increases response to substance increases expression increases expression
|
ISO
|
COX4I2 mRNA results in increased susceptibility to 3-nitropropionic acid 3-nitropropionic acid results in increased expression of COX4I2 mRNA 3-nitropropionic acid increases expression of Cox4i2 mRNA in primary astrocytes
|
CTD RGD |
PMID:19306371 PMID:19306371 |
RGD:13506652 |
NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:141,228,443...141,239,331
|
|
G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions decreases phosphorylation
|
EXP
|
N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of CREB1 protein]; Topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of CREB1 protein]
|
CTD |
PMID:29753867 PMID:36509115 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
|
|
G
|
Dnm1l
|
dynamin 1-like
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of DNM1L protein
|
CTD |
PMID:37116597 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
|
|
G
|
Eno2
|
enolase 2
|
decreases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased expression of ENO2 mRNA Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of ENO2 mRNA]
|
CTD |
PMID:17672854 |
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
multiple interactions increases expression
|
EXP
|
Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of GAPDH mRNA]
|
CTD |
PMID:21827809 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
|
|
G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] results in increased expression of GCLC mRNA
|
CTD |
PMID:22871521 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
|
|
G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased expression of GRIA2 mRNA topiramate inhibits the reaction [3-nitropropionic acid results in decreased expression of GRIA2 mRNA]
|
CTD |
PMID:29753867 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
|
|
G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
increases response to substance
|
EXP
|
GRIN2B protein results in increased susceptibility to 3-nitropropionic acid
|
CTD |
PMID:16919272 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
decreases phosphorylation multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased phosphorylation of GSK3B protein topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of GSK3B protein]
|
CTD |
PMID:29753867 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions decreases activity
|
EXP
|
naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]
|
CTD |
PMID:21945202 PMID:27206696 PMID:37116597 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] results in increased expression of GSTP1 mRNA
|
CTD |
PMID:22871521 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases activity
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] results in increased expression of HMOX1 mRNA; methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased activity of HMOX1 protein]]; Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased activity of HMOX1 protein]
|
CTD |
PMID:22871521 PMID:38513929 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of HSPA5 protein
|
CTD |
PMID:37116597 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of HSPA9 protein
|
CTD |
PMID:37116597 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
EXP
|
methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of IL1B protein]]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of IL1B protein]
|
CTD |
PMID:38513929 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
ISO
|
3-nitropropionic acid results in increased expression of IL6 mRNA delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of IL6 mRNA]
|
CTD |
PMID:28853159 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Itpr1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
decreases expression
|
EXP
|
3-nitropropionic acid results in decreased expression of ITPR1 protein
|
CTD |
PMID:37116597 |
|
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
|
|
G
|
Jak2
|
Janus kinase 2
|
increases phosphorylation multiple interactions
|
EXP
|
3-nitropropionic acid results in increased phosphorylation of JAK2 protein methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased phosphorylation of JAK2 protein]]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased phosphorylation of JAK2 protein]
|
CTD |
PMID:38513929 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions
|
ISO
|
3-nitropropionic acid inhibits the reaction [Curcumin results in increased localization of MAP1LC3B protein]
|
CTD |
PMID:37634662 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased phosphorylation of MAPK1 protein N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of MAPK1 protein]
|
CTD |
PMID:36509115 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions decreases phosphorylation
|
EXP
|
N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of MAPK3 protein]
|
CTD |
PMID:36509115 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G
|
Mapt
|
microtubule-associated protein tau
|
affects localization
|
EXP
|
3-nitropropionic acid affects the localization of MAPT protein
|
CTD |
PMID:17634376 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
|
|
G
|
Mfn1
|
mitofusin 1
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of MFN1 protein
|
CTD |
PMID:37116597 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:115,313,401...115,359,640
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression
|
EXP
|
3-nitropropionic acid results in decreased expression of MKI67 protein
|
CTD |
PMID:21827787 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions decreases expression
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein; methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of NFE2L2 protein]]; Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:22871521 PMID:38513929 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
decreases response to substance
|
ISO
|
NFKB1 results in decreased susceptibility to 3-nitropropionic acid
|
CTD |
PMID:11211235 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
increases expression multiple interactions
|
EXP ISO
|
3-nitropropionic acid results in increased expression of NOS2 mRNA; 3-nitropropionic acid results in increased expression of NOS2 protein N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 protein]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA] delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]; T 0070907 inhibits the reaction [delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]]
|
CTD |
PMID:22871521 PMID:28853159 PMID:36509115 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
EXP
|
[naringin co-treated with 3-nitropropionic acid] results in increased expression of NQO1 mRNA
|
CTD |
PMID:22871521 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
multiple interactions decreases phosphorylation
|
EXP
|
N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of NTRK2 protein]
|
CTD |
PMID:36509115 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
|
|
G
|
Penk
|
proenkephalin
|
decreases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased expression of PENK mRNA Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of PENK mRNA]
|
CTD |
PMID:17672854 |
|
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
|
|
G
|
Pick1
|
protein interacting with PRKCA 1
|
increases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in increased expression of PICK1 protein topiramate inhibits the reaction [3-nitropropionic acid results in increased expression of PICK1 protein]
|
CTD |
PMID:29753867 |
|
NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:110,797,117...110,816,848
|
|
G
|
Prkcd
|
protein kinase C, delta
|
multiple interactions
|
ISO
|
3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester results in increased cleavage of and results in increased phosphorylation of PRKCD protein]]
|
CTD |
PMID:37308051 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in increased expression of PTGS2 mRNA naringin inhibits the reaction [3-nitropropionic acid results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:22871521 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Rb1
|
RB transcriptional corepressor 1
|
decreases expression
|
EXP
|
3-nitropropionic acid results in decreased expression of RB1 protein
|
CTD |
PMID:21827787 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases phosphorylation multiple interactions
|
EXP
|
3-nitropropionic acid results in increased phosphorylation of RELA protein methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased phosphorylation of RELA protein]]; N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in increased phosphorylation of RELA protein]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased phosphorylation of RELA protein]
|
CTD |
PMID:36509115 PMID:38513929 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G
|
Sirt1
|
sirtuin 1
|
decreases expression
|
ISO EXP
|
3-nitropropionic acid results in decreased expression of SIRT1 protein
|
CTD |
PMID:18538940 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions decreases expression
|
EXP
|
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of SOD1 mRNA]
|
CTD |
PMID:17672854 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Sod2
|
superoxide dismutase 2
|
decreases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased expression of SOD2 mRNA Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of SOD2 mRNA]
|
CTD |
PMID:17672854 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G
|
Syp
|
synaptophysin
|
multiple interactions affects expression
|
EXP
|
Bezafibrate affects the reaction [3-nitropropionic acid affects the expression of SYP protein]
|
CTD |
PMID:37116597 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
|
|
G
|
Tac1
|
tachykinin, precursor 1
|
decreases expression multiple interactions
|
EXP
|
3-nitropropionic acid results in decreased expression of TAC1 mRNA Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of TAC1 mRNA]
|
CTD |
PMID:17672854 |
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions
|
EXP ISO
|
3-nitropropionic acid results in increased expression of TNF mRNA; 3-nitropropionic acid results in increased expression of TNF protein methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of TNF protein]]; N(6)-cyclohexyladenosine inhibits the reaction [3-nitropropionic acid results in increased expression of TNF protein]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]; Tropisetron inhibits the reaction [3-nitropropionic acid results in increased expression of TNF protein] delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]; T 0070907 inhibits the reaction [delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]]
|
CTD |
PMID:22871521 PMID:28853159 PMID:36509115 PMID:38513929 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Vdac1
|
voltage-dependent anion channel 1
|
increases expression
|
EXP
|
3-nitropropionic acid results in increased expression of VDAC1 protein
|
CTD |
PMID:37116597 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
|
|